https://www.almirall.fr 2026-07-20T10:00:48+00:00 weekly 1 https://www.almirall.fr/entreprise 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/entreprise/a-propos 2026-07-22T06:34:25+00:00 weekly 1 https://www.almirall.fr/entreprise/fournisseurs 2026-08-12T12:13:25+00:00 weekly 1 https://www.almirall.fr/entreprise/objectif 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/patients 2026-07-21T11:57:25+00:00 weekly 1 https://www.almirall.fr/entreprise/localisations 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/entreprise/durabilite/personnes 2026-07-20T10:35:53+00:00 weekly 1 https://www.almirall.fr/entreprise/durabilite/principes 2026-07-23T07:51:20+00:00 weekly 1 https://www.almirall.fr/patients/bien-etre-psychologique 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/patients/commitment/campaigns 2026-07-01T12:32:41+00:00 weekly 1 https://www.almirall.fr/entreprise/durabilite/planete 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/entreprise/durabilite 2026-08-18T06:54:01+00:00 weekly 1 https://www.almirall.fr/entreprise/durabilite/patients 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/entreprise/durabilite/partenaires 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/patients/histoires 2026-07-28T12:41:06+00:00 weekly 1 https://www.almirall.fr/patients/engagement/campagnes/sanctuary-salon 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/investisseurs 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/investisseurs/communications-CNMV 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/investisseurs/gouvernance-entreprise 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/investisseurs/gouvernance-entreprise/assemblee-generale 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/innovation/essais-cliniques 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/innovation/collaboration-rd 2026-07-20T11:53:36+00:00 weekly 1 https://www.almirall.fr/innovation/partenariats 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/investisseurs/gouvernance-entreprise/accords 2026-07-16T10:40:52+00:00 weekly 1 https://www.almirall.fr/investisseurs/gouvernance-entreprise/conseil-administration 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/gouvernance-entreprise/commissions-conseil 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/dermatologie 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/rapports/annuel 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/rapports/annuel/2021 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/innovation 2026-07-20T11:49:41+00:00 weekly 1 https://www.almirall.fr/investisseurs/informations-boursieres 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/informations-boursieres/performance-actions 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/informations-boursieres/capital-social 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/informations-boursieres/couverture-analystes 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/informations-boursieres/actions-financement 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/donnees-financieres/resultats-comptes 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/nvestisseurs/donnees-financieres/informations-publiques 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/donnees-financieres/materiels-information 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/innovation/pipeline 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/equipe-dirigeante 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/rapports 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/patients/engagement 2026-09-07T13:05:22+00:00 weekly 1 https://www.almirall.fr/investisseurs/gouvernance-entreprise/compliance 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/entreprise/integrite 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/entreprise/faq 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/entreprise/faq/produits 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/entreprise/faq/pathologie 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/entreprise/faq/domaines-therapeutiques 2026-07-16T10:40:59+00:00 weekly 1 https://www.almirall.fr/investisseurs/leadership/comite-direction 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/entreprise/histoire 2026-07-22T06:34:49+00:00 weekly 1 https://www.almirall.fr/investisseurs/gouvernance-entreprise/directeur-gouvernance 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/contact/signaler-effet-indesirable 2026-07-21T08:45:42+00:00 weekly 1 https://www.almirall.fr/actualites-medias/contact 2026-07-22T08:41:48+00:00 weekly 1 https://www.almirall.fr/actualites-medias/calendrier-evenements 2026-07-22T08:35:42+00:00 weekly 1 https://www.almirall.fr/contact/medias 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/contact/investisseurs 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/contact/recherche-developpement 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/contact/personnes-culture 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/contact/partenaires 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/contact/information-medicale 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/contact/aider-ameliorer 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/actualites-medias/ressources-medias 2026-07-22T09:02:01+00:00 weekly 1 https://www.almirall.fr/patients/engagement/campagnes/sanctuary-salon/patients 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/conditions-generales 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/entreprise/durabilite/transparence 2026-09-08T15:45:09+00:00 weekly 1 https://www.almirall.fr/global-privacy-policy 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/politique-confidentialite 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/politique-confidentialite-hcp 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/politique-accessibilite 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/politique-cookies 2026-07-16T10:41:06+00:00 weekly 1 https://www.almirall.fr/conditions-utilisation 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/securite-medicaments 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/entreprise/durabilite/autres-documents-pertinents 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/contact 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/avis-confidentialite-carrieres 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/politique-confidentialite-globale-evenements 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/professionnels-sante/produits 2026-07-16T10:46:19+00:00 weekly 1 https://www.almirall.fr/professionnels-sante 2026-07-16T10:45:55+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-atteint-les-objectifs-fixes-pour-2025-avec-une-croissance-de-124-de 2026-06-04T07:36:10+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/les-femmes-au-service-du-progres-scientifique 2026-06-04T07:44:24+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/les-progres-de-la-dermatologie-medicale-linnovation-grace-aux-collaborations-en 2026-06-04T07:43:01+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/une-approche-innee-penser-differemment-pour-faconner-lavenir-de-la-dermatologie 2026-06-26T08:08:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/skin-academy-faire-progresser-les-echanges-scientifiques-et-les-soins 2026-06-03T17:50:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-meets-guidance-2025-delivering-124-net-sales-growth-and-further 2026-04-22T14:31:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-continues-its-sustained-growth-trajectory-9m-2025-delivering-128-net 2026-04-15T11:42:19+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-presents-long-term-results-first-real-world-dermatology-study-using 2026-04-15T08:46:12+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-h1-2025-results-almirall-continues-deliver-its-long-term-growth 2026-04-15T11:44:35+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-delivers-strong-start-2025-growing-q1-overall-sales-15-and-234-its 2026-04-15T11:44:49+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-surpassed-guidance-2024-entering-era-sustained-growth-and-further 2026-04-15T11:45:04+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-nine-month-2024-results-almirall-reports-strong-performance-q3-2024 2026-04-15T11:45:23+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-q1-2024-results-almirall-delivers-strong-start-2024-q1-net-sales 2026-04-15T11:45:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-eloxx-pharmaceuticals-enter-exclusive-agreement-license-zkn-013 2026-04-15T10:32:19+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-achieves-net-sales-growth-64-driven-strong-european-dermatology 2026-04-15T11:47:05+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-achieves-net-sales-growth-7-eu4661mm-driven-strong-growth-european 2026-04-15T11:46:45+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-net-sales-reach-eu-232mm-and-increase-6-boosted-solid-european 2026-04-15T11:46:32+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-full-year-2022-results-almirall-closes-2022-core-net-sales-growth-66 2026-04-15T11:46:19+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-joins-facilitate-patient-driven-innovative-medicines-initiative-imi 2026-04-15T08:46:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-nine-month-2022-results-almirall-achieves-core-net-sales-eu6338-mm 2026-04-15T08:46:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-opens-new-subsidiary-czech-republic-and-slovakia 2026-04-15T08:46:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-chairman-carlos-gallardo-appointed-interim-ceo 2026-04-15T08:46:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-shedding-light-psoriasis-campaign-exposes-impact-disease-mental 2026-04-15T08:46:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-ema-acceptance-filing-marketing-authorization-application 2026-04-15T08:46:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-partners-chemical-institute-sarria-iqs-bring-pharmacy-students 2026-04-15T08:46:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-simcere-enter-licensing-agreement-il-2-mu-fc 2026-04-15T08:46:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-initiation-phase-i-study-anti-il-1rap-first-class-monoclonal 2026-04-15T08:46:43+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-lebrikizumab-dosed-every-four-weeks-maintained-durable-skin-clearance 2026-04-15T08:46:43+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-lebrikizumabs-52-week-late-breaking-data-will-be-presented-31st 2026-04-15T08:46:43+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-h1-2022-results 2026-04-15T08:46:43+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-new-call-find-innovative-therapies-skin-diseases 2026-04-15T08:46:44+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/happify-health-and-almirall-go-live-digital-solution-support-psoriasis-patients 2026-04-15T08:46:44+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-eight-out-ten-patients-maintained-skin-clearance-one-year-lebrikizumab 2026-04-15T08:46:44+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-initiates-decentralised-procedure-europe-treatment-mild-moderate 2026-04-15T08:46:44+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-innovative-wynzorar-cream-denmark-treatment-mild-moderate 2026-04-15T08:46:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-actinic-keratosis-ak-global-day-during-skin-cancer-awareness 2026-04-15T08:46:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-happify-health-go-live-digital-therapeutics-support-psoriasis 2026-04-15T08:46:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-evotec-enter-multi-target-alliance-medical-dermatology 2026-04-15T08:46:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-inserm-transfert-enter-licensing-and-research-collaboration 2026-04-15T08:46:47+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-delivers-good-business-performance-q1-and-reiterates-full-year-2022 2026-04-15T12:14:57+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/carlos-gallardo-asume-la-presidencia-de-almirall 2026-04-15T08:46:47+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-lebrikizumab-combined-topical-corticosteroids-showed-significant 2026-04-15T08:46:48+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-new-research-collaboration-university-dundee-develop 2026-04-15T08:46:48+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-majority-patients-treated-lebrikizumab-achieved-skin-clearance-pivotal 2026-04-15T08:46:48+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-collaboration-university-michigan-gain-understanding-disease 2026-04-15T08:46:48+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/dr-jorge-gallardo-ballart-announces-his-intention-retire-his-positions 2026-04-15T08:46:50+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-full-year-2021-results 2026-04-15T08:46:50+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-multi-target-licensing-agreement-ablexis-and-collaboration 2026-04-15T08:46:52+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-irb-barcelona-announce-research-collaboration-discover-novel 2026-04-15T08:46:52+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-lebrikizumab-demonstrated-significant-skin-improvement-and-itch-relief 2026-04-15T08:46:52+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/hoy-si-me-puedo-levantar-campaign-support-people-living-multiple-sclerosis-ms 2026-04-15T08:46:52+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/ichnos-sciences-and-almirall-enter-licensing-agreement-first-class-il-1rap 2026-04-15T08:46:53+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-delivers-solid-nine-months-2021-results-and-tightens-its-upgraded 2026-04-15T08:46:53+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-shedding-light-psoriasis-campaign-raise-awareness-world 2026-04-15T08:46:53+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-roadmap-more-sustainable-future 2026-04-15T08:46:55+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-pricing-eu300-million-issuance-senior-notes-due-2026 2026-04-15T08:46:55+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/lebrikizumab-significantly-improved-skin-clearance-and-itch-people-moderate 2026-04-15T08:46:56+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-delivers-robust-h1-performance-and-increases-full-year-guidance 2026-04-15T08:46:56+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-receives-european-commission-approval-klisyrir-v-tirbanibulin 2026-04-15T10:48:15+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-mc2-therapeutics-announce-completion-decentralized-procedure 2026-04-15T08:46:56+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-new-call-establish-partnerships-innovative-therapies-skin 2026-04-15T08:46:58+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-kaken-pharmaceutical-enter-license-and-distribution-agreement 2026-04-15T08:46:58+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-joins-biomap-new-partner-advance-field-inflammatory-skin-conditions 2026-04-15T08:46:58+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-appoints-dr-karl-ziegelbauer-chief-scientific-officer 2026-04-15T08:46:58+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-receives-fda-approval-produce-seysara-r-sarecycline-sant-andreu-de-la 2026-04-15T08:46:59+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-receives-positive-chmp-opinion-klisyrirv-tirbanibulin-innovative 2026-04-15T08:46:59+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-solid-core-business-q1-performance-boosted-growth-drivers-momentum 2026-04-15T08:46:59+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-proposes-ruud-dobber-new-member-its-board-directors 2026-04-15T08:46:59+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-receives-qualification-excellent-profarma-2020-program 2026-04-15T08:47:01+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-2020-full-year-results 2026-04-15T08:47:01+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-new-england-journal-medicine-publication-phase-iii-data 2026-04-15T08:47:01+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-new-publication-british-journal-dermatology-ilumetrirv 2026-04-15T08:47:02+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-gianfranco-nazzi-new-ceo 2026-04-15T08:47:02+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-happify-health-enter-strategic-partnership-develop-evidence 2026-04-15T08:47:02+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/cdp-recognizes-almirall-its-commitment-fight-against-climate-change 2026-04-15T08:47:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-tyris-therapeutics-enter-strategic-partnership-develop-next 2026-04-15T08:47:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-fda-approval-klisyrir-tirbanibulin-new-innovative-topical 2026-04-15T08:47:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-has-selected-six-digital-health-start-ups-join-second-harvest-digital 2026-04-15T08:47:04+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-collaborations-university-south-australia-and-fundacio 2026-04-15T08:47:04+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/popit-and-almirall-start-offering-new-support-tool-help-psoriasis-patients 2026-04-15T08:47:04+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/pablo-alvarez-appointed-president-and-gm-almirall-us 2026-04-15T08:47:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-demonstrates-resilient-performance-year-date-despite-covid-19-impacts 2026-04-15T08:47:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/board-directors-nominates-carlos-gallardo-vice-president-board 2026-04-15T08:47:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/first-complete-dataset-il-23p19-class-demonstrates-ilumetrirv-tildrakizumab 2026-04-15T08:47:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-its-second-innovation-initiative-dermatology-focused-digital 2026-04-15T08:47:07+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-approval-reimbursed-price-ilumetrirtildrakizumab-france 2026-04-15T08:47:07+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-university-dundee-announce-multi-target-research-collaboration 2026-04-15T08:47:07+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/ceo-peter-guenter-leave-almirall-31122020-pursue-new-opportunities 2026-04-15T08:47:08+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/sustained-performance-key-growth-drivers-and-excellent-progress-pipeline-h1 2026-04-15T08:47:08+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-calls-collaborative-innovation-advance-new-treatments-skin-diseases 2026-04-15T08:47:08+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-joins-amr-action-fund-support-fight-against-antimicrobial-resistance 2026-04-15T08:47:10+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-enters-ibex-35 2026-04-15T08:47:10+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-e-ms-experts-summit-season-2020 2026-04-15T08:47:10+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-uc3m-and-medina-foundation-research-new-treatments-rare-genetic 2026-04-15T08:47:11+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/solid-q1-2020-performance 2026-04-15T08:47:11+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-ensure-business-continuity-all-drugs-essential-patients 2026-04-15T08:47:11+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announcement 2026-04-15T08:47:12+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-fda-acceptance-filing-us-new-drug-application-nda 2026-04-15T08:47:12+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-ema-acceptance-filing-marketing-authorization-application-0 2026-04-15T08:47:12+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-full-year-2019-results-strong-operational-performance-excellent 2026-04-15T08:47:12+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-paratek-enter-license-agreement-seysarar-china 2026-04-15T08:47:14+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-partners-plug-and-play-accelerate-digital-innovation-dermatology 2026-04-15T12:17:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-participate-jp-morgan-healthcare-conference-san-francisco 2026-04-15T08:47:16+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-signs-strategic-agreement-23andme-license-rights-bispecific-monoclonal 2026-04-15T08:47:16+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-wuxi-biologics-sign-strategic-collaboration-agreement-multiple 2026-04-15T08:47:16+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-enters-option-agreement-acquire-bioniz-therapeutics-and-establish 2026-04-15T08:47:16+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirallshare-responsible-50-private-public-collaborations-almirall 2026-04-15T08:47:18+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-iktos-announce-research-collaboration-artificial-intelligence-new 2026-04-15T08:47:18+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/volker-koscielny-new-chief-medical-officer-and-new-member-management-board 2026-04-15T08:47:18+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-accelerator-digital-garden-drive-digital-innovation 2026-04-15T08:47:18+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/majority-shareholders-almirall-give-mandate-increase-free-float 2026-04-15T08:47:20+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-llc-announces-publication-long-term-safety-data-use-seysarar 2026-04-15T08:47:20+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-9m-2019-business-results-continued-good-business-momentum-driven 2026-04-15T08:47:20+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/duaklirr-will-be-available-united-states-21st-october 2026-04-15T08:47:20+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/tildrakizumab-confirms-its-long-term-efficacy-and-safety-longest-il23p19-data 2026-04-15T08:47:22+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-initiation-phase-3-program-evaluating-lebrikizumab-patients 2026-04-15T08:47:22+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-takes-leap-dermatology-digital-health-innovation 2026-04-15T08:47:22+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-cfo-leadership-transition-mike-mcclellan-join-almirall 2026-04-15T08:47:22+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/scottish-medicines-consortium-smc-provisionally-approves-almiralls-ilumetrirv 2026-04-15T08:47:24+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-h1-2019-continued-strong-business-momentum-while-reinforcing-pipeline 2026-04-15T08:47:24+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-calls-partners-develop-new-immune-dermatology-therapies 2026-04-15T08:47:24+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-revalidates-its-excellence-occupational-health-and-safety-environment 2026-04-15T08:47:24+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-exercises-its-option-dermira-license-rights-lebrikizumab-europe-atopic 2026-04-15T08:47:26+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/investment-plan-europe-eib-finances-almiralls-research-new-skin-disease 2026-04-15T08:47:26+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-q1-2019-strong-operating-performance 2026-04-15T08:47:26+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/nice-publishes-final-recommendation-almiralls-ilumetrirv-tildrakizumab-cost 2026-04-15T08:47:26+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-recognized-distinguished-corporate-leader-american-skin-association 2026-04-15T08:48:25+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/fda-approves-duaklirr-new-drug-application-chronic-obstructive-pulmonary 2026-04-15T08:48:25+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-hitgen-will-develop-novel-oral-compounds-atopic-dermatitis 2026-04-15T08:48:25+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/nice-provisionally-approves-almiralls-ilumetrirv-tildrakizumab-cost-effective 2026-04-15T08:48:25+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase 2026-04-15T10:50:11+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-nuevolution-partnership-achieves-first-collaboration-milestone 2026-04-15T08:48:26+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-full-year-2018-results 2026-04-15T08:48:26+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-dermira-enter-option-and-license-agreement-european-rights 2026-04-15T08:48:26+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirallshare-successful-platform-find-innovative-solutions-medical-dermatology 2026-04-15T08:48:28+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-late-breaking-oral-presentation-kx2-391-ointment-two-phase-0 2026-04-15T08:48:28+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/novel-oral-antibiotic-treatment-seysaratm-sarecycline-now-available-us 2026-04-15T08:48:28+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/francesca-domenech-wuttke-new-chief-digital-officer-and-new-member-management 2026-04-15T08:48:29+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-sa-present-jp-morgan-healthcare-conference-san-francisco 2026-04-15T08:48:29+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-successful-pricing-eu250-mm-offering-senior-unsecured 2026-04-15T08:48:29+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-refinance-us-medical-dermatology-acquisition 2026-04-15T08:48:29+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-ilumetrir-germany-moderate-severe-chronic-plaque-psoriasis 2026-04-15T08:48:31+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-9m-2018-business-results-strong-business-momentum 2026-04-15T08:48:31+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/fda-approves-seysaratm-new-chemical-entity-moderate-severe-acne 2026-04-15T08:48:31+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-closes-agreement-allergan-and-acquires-its-us-medical-dermatology 2026-04-15T08:48:32+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/european-commission-approves-almiralls-ilumetrir-tildrakizumab-moderate-severe 2026-04-15T08:48:32+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/transformational-transaction-almirall-acquire-us-medical-dermatology-portfolio 2026-04-15T08:48:32+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/strong-h1-2018-business-results-upgrading-ebitda-guidance 2026-04-15T08:48:34+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-receives-positive-chmp-opinion-new-anti-il23-tildrakizumab-treatment 2026-04-15T08:48:34+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-both-phase-iii-trials-kx2-391-actinic-keratosis-achieved 2026-04-15T08:48:34+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/thermi-announces-settlement-patent-infringement-litigation-viveve 2026-04-15T08:48:35+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-q1-2018-encouraging-financial-results 2026-04-15T08:48:35+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-full-year-2017-results 2026-04-15T08:48:35+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/thermi-and-sinclair-terminate-their-collaboration-silhouette-instalift-tm 2026-04-15T10:50:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-athenex-announce-strategic-partnership-treatment-actinic-keratosis 2026-04-15T08:48:36+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/phase-iv-ascent-trial-shows-tudorza-reduces-copd-exacerbations-and-demonstrates 2026-04-15T08:48:36+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-q3-results-2017 2026-04-15T08:48:36+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/new-randomized-controlled-study-confirms-efficacy-and-tolerability-profile 2026-04-15T08:48:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-skilarencer-europe-moderate-severe-chronic-plaque-psoriasis 2026-04-15T08:48:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-renews-its-corporate-identity-aligned-its-focus-skin-health 2026-04-15T08:48:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/phase-iii-amplify-study-shows-duaklir-significantly-improves-lung-function 2026-04-15T08:48:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-appoints-peter-guenter-new-ceo 2026-04-15T08:48:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-h1-results-2017-reiterating-recent-guidance 2026-04-15T08:48:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-collaborates-icmab-csic-and-leitat-technology-center-nanomedicine 2026-04-15T08:48:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-guidance-update-2017 2026-04-15T08:48:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/international-experts-elaborate-consensus-effects-present-and-potential-medical 2026-04-15T08:48:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-q1-results-2017-driven-dermatology-europe 2026-04-15T08:48:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/data-tildrakizumab-clinical-development-program-presented-2017-american-academy 2026-04-15T08:48:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-full-year-2016-results-strong-dermatology-results-and-promising 2026-04-15T08:48:43+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-y-mercachem-anuncian-una-colaboracion-para-el-desarrollo-de 2026-04-15T08:48:43+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-nuevolution-enter-strategic-collaboration-develop-rorgt-inhibitors 2026-04-15T08:48:43+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-9m-results-2016-strong-derma-performance-eu-and-solid-progress-us 2026-04-15T08:48:43+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-restructuring-plan-spain 2026-04-15T08:48:44+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-h1-results-2016-growth-total-revenues-and-net-sales-driven-dermatology 2026-04-15T08:48:44+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-bicosome-enter-collaboration-and-sublicense-agreement-development 2026-04-15T08:48:44+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-q1-results-2016-track-achieve-yearly-guidance 2026-04-15T08:48:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-reduces-its-accident-rate-69-spain-2015 2026-04-15T08:48:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-full-year-2015-results-normalized-net-income-growth-90 2026-04-15T08:48:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-closes-acquisition-thermigen-llc-entering-aesthetics-market 2026-04-15T08:48:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-exercises-call-option-acquire-100-thermigen-llc 2026-04-15T08:48:47+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-reaches-agreement-acquire-100-poli-group 2026-04-15T08:48:47+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-has-acquired-rights-veltinr-and-altabaxr-stiefel-gsk-company-exchange 2026-04-15T08:48:47+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-september-ytd-results-2015-operational-business-outperformance-driven 2026-04-15T08:48:48+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-closes-15-million-strategic-investment-suneva-medical 2026-04-15T08:48:48+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-h1-results-2015-growth-driven-strong-sales-increase-dermatology 2026-04-15T08:48:48+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-q1-results-2015-growth-acceleration-driven-dermatology 2026-04-15T08:48:48+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-full-year-2014-results-line-guidance 2026-04-15T08:48:50+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-finaliza-el-acuerdo-con-astrazeneca-en-el-area-respiratoria 2026-04-15T08:48:50+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-aclidinium-bromideformoterol-fumarate-recommended-approval-europe 2026-04-15T08:48:50+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-agrees-strategic-transaction-astrazeneca-respiratory-disease 2026-04-15T08:48:50+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-h1-results-2014-continued-growth-acceleration 2026-04-15T08:48:51+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-q1-results-2014-growth-acceleration 2026-04-15T08:48:51+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/forest-laboratories-and-almirall-provide-update-fixed-dose-combination 2026-04-15T08:48:51+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/index-pharmaceuticals-and-almirall-enter-license-agreement-european-rights 2026-04-15T12:22:28+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-completed-senior-notes-pricing-325-million-euros-7-year-maturity-and 2026-04-15T12:23:00+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-accident-rate-spain-2013-down-20 2026-04-15T08:48:53+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-full-year-results-2013-setting-foundations-accelerating-growth 2026-04-15T08:48:53+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-reaches-agreement-implement-reestructuring-plan-spain 2026-04-15T08:48:54+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-reaches-agreement-acquire-aqua-pharmaceuticals-us-based-specialty 2026-04-15T12:23:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-reorganization-program-affecting-group-europe 2026-04-15T08:48:54+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/around-clock-symptom-relief-vital-many-millions-chronic-obstructive-pulmonary 2026-04-15T08:48:54+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-q3-track-deliver-year-guidance-eklirar-genuairr-s-global-rollout 2026-04-15T08:48:56+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/aclidinium-and-formoterol-fixed-dose-combination-copd-submitted-registration 2026-04-15T08:48:56+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/aclidinium-chosen-one-best-spanish-therapeutic-innovations-international-reach 2026-04-15T08:48:56+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/new-data-reinforce-efficacy-and-safety-profile-sativexr-multiple-sclerosis 2026-04-15T08:48:56+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/importance-24-hours-symptom-relief-those-suffering-copd 2026-04-15T08:48:57+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/international-pharmaceutical-company-almirall-expands-global-footprint-new 2026-04-15T08:48:57+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-h1-executing-growth-platforms-financial-delivery-track 2026-04-15T08:48:57+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-50-below-pharmaceutical-sector-accident-rate 2026-04-15T08:48:57+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-maintains-its-commitment-environment-spain-and-germany 2026-04-15T08:48:59+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-pioneer-spain-being-awarded-iso-500012011-energy-management-system 2026-04-15T08:48:59+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/constellar-linaclotide-first-approved-prescription-therapy-new-class-treatments 2026-04-15T12:24:11+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/survey-reveals-two-five-european-persons-multiple-sclerosis-ms-under-35-are 2026-04-15T12:25:04+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-begins-transformation 2026-04-15T08:49:00+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-second-phase-iii 2026-04-15T12:26:17+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-announce-positive-results-phase-iii-study 2026-04-15T08:49:01+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-presents-latest-news-respiratory-diseases 2026-04-15T08:49:01+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/2012-results-line-guidance-positioning-almirall-transformative-growth-2013 2026-04-15T08:49:01+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/coordination-among-professionals-crucial-good-vascular-patient-care 2026-04-15T08:49:01+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-commercialises-neurofarmagen-innovative-genetic-test 2026-04-15T08:49:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/eklirar-genuairr-almirall-available-spain-treatment-copd 2026-04-15T08:49:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-celebrates-10-years-italy 2026-04-15T08:49:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-financial-calendar-2013 2026-04-15T08:49:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-announce-commercial-availability-tudorzatm 2026-04-15T12:27:34+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/constellar-linaclotide-approved-europe-treatment-irritable-bowel-syndrome 2026-04-15T12:28:32+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-appoints-karin-louise-dorrepaal-new-independent-board-member 2026-04-15T08:49:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/3rd-quarter-results 2026-04-15T08:49:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/low-awareness-chronic-obstructive-pulmonary-disease-copd-confirmed-recent 2026-04-15T12:29:08+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-invests-personalised-medicine-becoming-part-share-capital-ab-biotics 2026-04-15T11:57:50+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-incorporates-gerhard-mayr-board-directors 2026-04-15T08:49:08+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/sativexr-confirms-clinically-relevant-benefits-multiple-sclerosis-spasticity 2026-04-15T08:49:08+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-licenses-aclidinium-invida-australia-and 2026-04-15T08:49:08+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-eklirar-genuairr-aclidinium-europe 2026-04-15T10:58:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-obtains-rights-linaclotide-mexico 2026-04-15T08:49:10+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/eklirar-genuairr-provides-meaningful-and-sustained-bronchodilation-first-dose 2026-04-15T11:51:55+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/eklirarbretarisr-genuairr-aclidinium-bromide-approved-europe-maintenance 2026-04-15T11:56:55+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-announce-fda-approval-tudorzatm-pressairtm 2026-04-15T12:30:18+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/abediterol-almiralls-od-laba-shows-superiority-vs-indacaterol-phase-iia 2026-04-15T12:31:07+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/aclidinium-clinical-data-published-european-respiratory-journal-confirms 2026-04-15T12:31:50+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-supports-european-post-graduate-clinical-research-ms-spasticity-two 2026-04-15T12:32:28+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/sativexr-starts-new-wave-regulatory-submissions-europe 2026-04-15T12:32:58+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-starts-phase-iii-aclidinium-and-formoterol-copd 2026-04-15T12:33:53+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-roflumilast-spain 2026-04-24T12:32:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-nycomed-announce-licensing-agreement-ebastine-china-and-other-key 2026-04-15T11:40:56+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/una-nueva-guia-ayudara-los-medicos-en-el-manejo-de-la-osteoporosis 2026-04-15T11:55:17+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-appoints-alfredo-baron-area-director-southern-and-eastern-europe 2026-04-15T11:37:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/farid-taha-new-general-manager-almirall-germany-austria-and-switzerland 2026-04-15T11:36:52+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/nuevos-datos-avalan-la-seguridad-y-la-eficacia-del-bazedoxifeno-para-prevenir 2026-04-15T11:53:42+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-empresa-comprometida-con-la-formacion-de-los-gestores-sanitarios 2026-04-15T11:54:04+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/daniel-martinez-carretero-appointed-chief-financial-officer-cfo-almirall 2026-04-15T11:37:15+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-annual-general-meeting-approves-dividend-029-euros-share 2026-04-15T11:34:47+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-nycomed-announce-commercialization-agreement-roflumilast-spain 2026-04-15T11:35:20+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-strengthens-its-respiratory-franchise-new-generation-chronic 2026-04-15T11:36:00+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-apuesta-por-la-formacion-gestores-sanitarios-en-un-modelo-efectivo-de 2026-04-15T11:36:11+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-excellent-company-according-profarma-plan-ministry-industry-tourism 2026-04-15T11:32:51+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/ignasi-marti-rague-director-institutional-relations-almirall 2026-04-15T11:36:29+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-appointment-eduardo-sanchiz-new-ceo-july-1st-2011 2026-04-15T12:35:21+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/sativexr-launched-spain-treat-spasticity 2026-04-15T08:49:54+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-kyorin-announce-licensing-agreement-japan-aclidinium-bromide 2026-04-15T11:33:09+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-appoints-eloi-crespo-new-general-director-industrial-area 2026-04-15T11:33:36+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/el-manejo-precoz-del-paciente-diabetico-clave-para-conseguir-una-prevencion 2026-04-15T11:34:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/sativex-granted-reimbursement-spain-treatment-spasticity-multiple-sclerosis 2026-04-15T08:49:55+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-mexico-receives-distinction-companies-transparent-practices 2026-04-15T11:31:18+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/los-ultimos-avances-debate-en-el-x-symposium-de-psiquiatria-organizado-por 2026-04-15T11:30:46+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/bertil-lindmark-new-executive-director-rd-almirall 2026-04-21T10:00:56+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-forest-announce-positive-results-attain-phase-iii-study-aclidinium 2026-04-15T11:29:54+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/sativexr-enters-phase-iii-clinical-programme-oncological-pain 2026-04-15T08:49:58+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-ironwood-announce-positive-results-second-phase-iii-trial 2026-04-15T08:49:58+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-forest-report-preliminary-topline-results-accord-copd-ii-phase-iii 2026-04-15T08:50:00+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-apoya-el-programa-de-actividades-puesto-en-marcha-por-la-sed-y-su 2026-04-15T11:32:29+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/sativexr-data-presented-ectrims-congress-highlights-its-efficacy-add-therapy 2026-04-15T08:50:00+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-pioneer-obtaining-ohsas-18001-occupational-health-and-safety-renews 2026-04-15T11:12:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/launch-spain-urorecrsilodyxtm-new-treatment-symptoms-associated-benign 2026-04-15T11:12:13+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/conbrizar-bazedoxifene-approved-spanish-agency-medicines-and-healthcare 2026-04-15T11:17:45+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/research-chronic-pain-winning-project-pharmacology-award-presented-almirall-and 2026-04-15T11:10:40+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-receives-company-rating-excellent-ministry-industry-tourism-and-trade 2026-04-15T08:50:02+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-ironwood-announce-positive-results-phase-3-trial-linaclotide 2026-04-15T11:10:07+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-awarded-zero-rate-accident-frequency-2009 2026-04-15T11:28:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-signs-co-promotion-agreement-pfizer-commercialise-conbrizar-spain-new 2026-04-15T11:28:36+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-reaffirms-its-commitment-environment-renewal-its-iso-140012004 2026-04-15T11:09:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/el-tratamiento-integral-de-la-diabetes-tipo-2-y-su-cumplimiento-por-parte-del 2026-04-15T11:09:06+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/presentation-neogenius-project-brings-together-around-hundred-investigators 2026-04-15T08:50:05+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-international-agreement-basilea-commercialize-toctinor 2026-04-15T12:39:04+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-organiza-la-i-reunion-de-centros-de-excelencia-en-cardiologia-de 2026-04-15T12:39:28+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-annual-general-meeting-approves-dividend-033-euros-share-figure-5 2026-04-15T08:50:08+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-first-quarter-2010-track 2026-04-15T08:50:08+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-forest-present-data-studies-eklirar-aclidinium-bromide-chronic 2026-04-15T08:50:10+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/20-years-antihistamine-ebastelr-ebastine 2026-04-15T08:50:10+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-grants-eisai-marketing-rights-cinitapride-china 2026-04-15T08:50:10+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-thiomucase-extreme-areas-first-anti-cellulite-stick 2026-04-15T08:50:11+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-solid-performance-2009-setting-basis-sustainable-long-term-growth 2026-04-15T11:08:37+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/neogenius-alliance-between-almirall-esteve-palau-pharma-and-proteomika 2026-04-15T08:50:11+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/multidisciplinary-approach-improve-treatment-and-reduce-patient-cardiovascular 2026-04-15T08:50:12+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/silodosin-indicated-benign-prostatic-hyperplasia-bph-has-been-approved-european 2026-04-15T08:50:12+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-strengthens-its-focus-twice-daily-dosing-eklirar-chronic-obstructive 2026-04-15T08:50:12+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/9th-psychiatry-symposium-organized-almirall-presents-latest-advances-area 2026-04-15T08:50:14+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-forest-announce-positive-results-accord-copd-i-phase-iii-study 2026-04-15T08:50:14+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-forest-laboratories-expand-respiratory-collaboration-las100977 2026-04-15T08:50:14+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-parapres-plus-32r-and-parapres-plus-forter-treat-hypertension 2026-04-15T08:50:14+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/emeachmp-adopts-positive-opinion-silodosin 2026-04-15T08:50:15+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-reports-net-sales-7013-million-euros-increase-24 2026-04-15T08:50:15+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-dhodh-inhibitor-recognized-windhover-top-10-partnering-list 2026-04-15T08:50:15+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-us-15-m-equity-investment-ironwood-pharmaceuticals 2026-04-15T08:50:16+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/update-eklirar-aclidinium-bromide-chronic-obstructive-pulmonary-disease-copd 2026-04-15T11:24:03+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/blastoactiva-first-skin-cell-repair-cream-double-select-centella-asiatica 2026-04-15T08:50:16+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-spanish-society-pharmacology-present-8th-pharmacology-award-2009 2026-04-15T08:50:16+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-aims-file-once-daily-aclidinium-bromide-copd-europe-early-2010 2026-04-15T08:50:18+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-reports-over-103-million-euros-net-income-first-half-year-2009 2026-04-15T08:50:18+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-offers-its-employees-6500-hours-training-health-and-safety 2026-04-15T08:50:18+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-appoints-new-managing-director-its-market-company-poland 2026-04-15T08:50:19+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almotriptan-axertralmogranr-approved-fda-treatment-migraine-adolescents 2026-04-15T08:50:19+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-awards-dividend-payments-52-million-euros-its-shareholders 2026-04-15T08:50:19+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-reports-over-63-million-euros-net-income-first-quarter-2009 2026-04-15T08:50:21+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-launches-efficibr-spain-combination-product-sitagliptin-and-metformin 2026-04-15T08:50:22+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-signs-pan-european-licensing-agreement-ironwood-linaclotide-novel 2026-04-15T08:50:22+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-opens-its-doors-pharmaceutical-industry-mark-opening-new-london 2026-04-15T08:50:23+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/steve-webber-new-senior-discovery-director-almirall 2026-04-15T08:50:23+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-signs-co-marketing-agreement-recordati-marketing-silodosin-spain-new 2026-04-15T08:50:25+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-obtains-net-income-1361-million-euros-2008-38-more-previous-year 2026-04-15T08:50:25+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/encouraging-results-support-further-development-almiralls 2026-04-15T10:32:15+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/between-15-and-20-population-will-suffer-depression-some-time-during-their 2026-04-15T11:21:30+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/promising-results-almiralls-once-daily-long-acting-beta-agonist-laba-expected 2026-04-15T08:50:36+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/marc-ayas-new-director-international-human-resources-and-compensation-almirall 2026-04-15T08:50:36+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-ranke-quimica-reduced-its-accident-rate-57-2007 2026-04-15T08:50:36+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-obtains-total-revenues-around-809-million-euros-18-more-same-period 2026-04-15T08:50:36+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-signs-agreement-pfizer-commercialise-new-medicine-reduces 2026-04-15T08:50:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-signs-co-marketing-agreement-msd-commercialise-spain-new-medicine-type 2026-04-15T08:50:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/daniel-martinez-takes-new-position-deputy-cfo-almirall 2026-04-15T08:50:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-upgrades-its-company-website-wwwalmirallcom 2026-04-15T08:50:38+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-moving-forward-development-aclidinium-bromide 2026-04-15T11:20:44+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-receipt-15-million-dollars-eu105-million-forest-laboratories 2026-04-15T10:32:07+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-announces-initial-agreement-sale-its-plant-sant-just-desvern-lesvi 2026-04-15T08:50:41+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-receives-fundamed-el-global-award-best-pharmaceutical-company-year 2026-04-15T11:03:47+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-council-catalonian-medical-associations-fundacio-galatea-sign 2026-04-15T11:04:51+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-spa-be-awarded-spanish-company-year-italy 2026-04-15T11:05:11+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/el-dr-carsten-niederlander-nuevo-director-de-desarrollo-farmaceutico 2026-04-15T12:38:20+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/dr-olof-andersson-new-executive-director-rd-area-almirall 2026-04-15T11:05:34+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-reveals-promising-phase-ii-data-its-once-daily-long-acting-low 2026-04-15T10:32:27+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-confers-2003-pharmacology-award 2026-04-15T11:06:13+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-presents-its-new-corporate-website 2026-04-15T11:14:53+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-has-licensed-its-triptan-ortho-mcneil-pharmaceutical-inc-us-and-canada 2026-04-15T11:15:28+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-inaugurates-offices-china-advance-innovation-medical-dermatology 2026-04-30T09:02:10+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/lebrikizumab-delivered-significant-skin-clearance-and-improved-disease-severity 2026-04-30T09:49:44+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almiralls-17th-skin-academy-highlights-scientific-advances-inflammatory-skin 2026-04-30T09:08:27+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/aad-2026-almirall-presents-new-clinical-and-real-world-evidence-across-atopic 2026-04-30T09:24:15+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-enters-collaboration-huaota-development-novel-monoclonal-antibody 2026-04-30T09:28:50+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/lebrikizumab-delivered-long-term-disease-control-four-years-patients-moderate 2026-04-30T09:37:48+00:00 weekly 1 https://www.almirall.fr/news-media/newsroom/almirall-and-barcelona-supercomputing-center-expand-their-collaboration 2026-04-30T09:47:14+00:00 weekly 1 https://www.almirall.fr/dermatologie/acne 2026-08-17T12:21:49+00:00 weekly 1 https://www.almirall.fr/dermatologie/alopecie-plaques 2026-08-17T10:47:14+00:00 weekly 1 https://www.almirall.fr/dermatologie/cancer-keratinocytaire 2026-08-17T10:55:26+00:00 weekly 1 https://www.almirall.fr/dermatologie/dermatite-atopique 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/cancer-keratinocytaire/diagnostic 2026-07-21T08:27:20+00:00 weekly 1 https://www.almirall.fr/dermatologie/alopecie-plaques/diagnostic 2026-08-17T12:35:25+00:00 weekly 1 https://www.almirall.fr/dermatologie/hidradenite-suppuree/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/onychomycose/diagnostic 2026-08-17T11:34:42+00:00 weekly 1 https://www.almirall.fr/dermatologie/dermatite-atopique/diagnostic 2026-07-21T07:47:31+00:00 weekly 1 https://www.almirall.fr/dermatologie/keratose-actinique/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/acne/diagnostic 2026-07-21T07:51:29+00:00 weekly 1 https://www.almirall.fr/dermatologie/psoriasis/diagnostic 2026-08-17T12:04:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/vitiligo/diagnostic 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/facteurs-declenchants 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/facteurs-declenchants 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/acne/facteurs-declenchants 2026-07-16T10:41:16+00:00 weekly 1 https://www.almirall.fr/dermatologie/hidradenite-suppuree/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/dermatite-atopique/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/keratose-actinique/facteurs-declenchants 2026-08-17T12:23:43+00:00 weekly 1 https://www.almirall.fr/dermatologie/psoriasis/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/onychomycose/facteurs-declenchants 2026-08-17T11:02:42+00:00 weekly 1 https://www.almirall.fr/dermatologie/cancer-keratinocytaire/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/alopecie-plaques/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/vitiligo/facteurs-declenchants 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/hidradenite-suppuree 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/keratose-actinique 2026-08-17T12:37:41+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/onychomycose 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/psoriasis 2026-08-17T12:52:49+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/cancer-keratinocytaire/symptomes-manifestations 2026-07-21T09:42:51+00:00 weekly 1 https://www.almirall.fr/dermatologie/alopecie-plaques/symptomes-manifestations 2026-07-21T08:09:34+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/symptomes-manifestations 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/hidradenite-suppuree/symptomes-manifestations 2026-07-21T08:35:57+00:00 weekly 1 https://www.almirall.fr/dermatologie/dermatite-atopique/symptomes-manifestations 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/keratose-actinique/symptomes-manifestations 2026-08-17T12:26:14+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/symptomes-manifestations 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/acne/symptomes-manifestations 2026-08-17T11:12:56+00:00 weekly 1 https://www.almirall.fr/dermatologie/onychomycose/symptomes-manifestations 2026-08-17T11:20:17+00:00 weekly 1 https://www.almirall.fr/dermatologie/vitiligo/symptomes-manifestations 2026-07-16T10:41:21+00:00 weekly 1 https://www.almirall.fr/dermatologie/psoriasis/symptomes-manifestations 2026-08-17T11:47:55+00:00 weekly 1 https://www.almirall.fr/dermatologie/cancer-keratinocytaire/traitement 2026-07-21T09:40:17+00:00 weekly 1 https://www.almirall.fr/dermatologie/alopecie-plaques/traitement 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/traitement 2026-07-21T08:40:03+00:00 weekly 1 https://www.almirall.fr/dermatologie/hidradenite-suppuree/traitement 2026-07-21T08:33:34+00:00 weekly 1 https://www.almirall.fr/dermatologie/dermatite-atopique/traitement 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/keratose-actinique/traitement 2026-07-21T07:31:31+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/traitement 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/acne/traitement 2026-08-17T11:09:53+00:00 weekly 1 https://www.almirall.fr/dermatologie/psoriasis/traitement 2026-08-17T11:37:19+00:00 weekly 1 https://www.almirall.fr/dermatologie/vitiligo/traitement 2026-07-21T08:31:09+00:00 weekly 1 https://www.almirall.fr/dermatologie/onychomycose/traitement 2026-07-21T09:37:34+00:00 weekly 1 https://www.almirall.fr/dermatologie/alopecie-plaques/types 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/epidermolyse-bulleuse-congenitale/types 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/hidradenite-suppuree/types 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/onychomycose/types 2026-07-21T08:06:19+00:00 weekly 1 https://www.almirall.fr/dermatologie/cancer-keratinocytaire/types 2026-08-17T11:04:47+00:00 weekly 1 https://www.almirall.fr/dermatologie/dermatite-atopique/types 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/keratose-actinique/types 2026-08-17T12:32:34+00:00 weekly 1 https://www.almirall.fr/dermatologie/psoriasis/types 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/maladies-rares-peau/pustulose-palmoplantaire/types 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/vitiligo/types 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/acne/types 2026-07-16T10:41:24+00:00 weekly 1 https://www.almirall.fr/dermatologie/vitiligo 2026-07-16T10:41:24+00:00 weekly 1